Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Selling Molson Coors Brewing Company (NYSE:TAP)

Molson Coors Brewing Company (NYSE:TAP) was in 22 hedge funds’ portfolio at the end of the fourth quarter of 2012. TAP investors should pay attention to a decrease in enthusiasm from smart money of late. There were 24 hedge funds in our database with TAP positions at the end of the previous quarter.

Molson Coors Brewing Company (NYSE:TAP)

To the average investor, there are plenty of indicators investors can use to monitor Mr. Market. A pair of the most underrated are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the top fund managers can trounce their index-focused peers by a very impressive amount (see just how much).

Equally as key, bullish insider trading activity is a second way to parse down the financial markets. There are a variety of reasons for an upper level exec to drop shares of his or her company, but just one, very simple reason why they would behave bullishly. Several empirical studies have demonstrated the useful potential of this strategy if you understand what to do (learn more here).

With all of this in mind, it’s important to take a look at the key action encompassing Molson Coors Brewing Company (NYSE:TAP).

What have hedge funds been doing with Molson Coors Brewing Company (NYSE:TAP)?

In preparation for this year, a total of 22 of the hedge funds we track held long positions in this stock, a change of -8% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few noteworthy hedge fund managers who were upping their stakes significantly.

When looking at the hedgies we track, Richard S. Pzena’s Pzena Investment Management had the most valuable position in Molson Coors Brewing Company (NYSE:TAP), worth close to $111 million, accounting for 0.9% of its total 13F portfolio. On Pzena Investment Management’s heels is Levin Capital Strategies, managed by John A. Levin, which held a $97 million position; the fund has 1.9% of its 13F portfolio invested in the stock. Remaining hedge funds with similar optimism include David Costen Haley’s HBK Investments, Martin D. Sass’s MD Sass and Jim Simons’s Renaissance Technologies.

Seeing as Molson Coors Brewing Company (NYSE:TAP) has witnessed bearish sentiment from the smart money, it’s safe to say that there is a sect of hedge funds who sold off their entire stakes at the end of the year. At the top of the heap, Mark Travis’s Intrepid Capital Management sold off the largest position of the “upper crust” of funds we monitor, comprising close to $15 million in stock.. Bart Baum’s fund, Ionic Capital Management, also sold off its call options., about $9 million worth. These moves are intriguing to say the least, as aggregate hedge fund interest dropped by 2 funds at the end of the year.

How have insiders been trading Molson Coors Brewing Company (NYSE:TAP)?

Insider buying is at its handiest when the company in question has experienced transactions within the past half-year. Over the latest six-month time period, Molson Coors Brewing Company (NYSE:TAP) has seen zero unique insiders buying, and 5 insider sales (see the details of insider trades here).

With the results shown by Insider Monkey’s time-tested strategies, everyday investors must always watch hedge fund and insider trading sentiment, and Molson Coors Brewing Company (NYSE:TAP) shareholders fit into this picture quite nicely.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!